Is Netflix raising subscription cost to $49.99 as of March 1?

At a Feb. 3, 2026 Senate antitrust subcommittee hearing, Netflix co‑CEO Ted Sarandos suggested any subscription price increase would depend on perceived consumer value while defending Netflix’s proposed acquisition of Warner Bros. A viral claim that Netflix would raise its monthly fee to $49.99 starting March 1 originated from a parody account and is unverified; Netflix last raised its Premium plan to $24.99 in January 2025. The Warner Bros. deal, which would include HBO/HBO Max, remains under regulatory review and could close in 2026, and the impact on subscriber pricing remains unclear.

Analysis

Market structure: If Netflix (NFLX) completes a Warner Bros. buy, Netflix and WBD shareholders are primary beneficiaries — scale and HBO content could lift ARPU by $1–$3/month; at ~250M paid subs that equals roughly $3–$9B incremental revenue run-rate per $1 ARPU. Losers would be mid‑tier streamers (DIS, PARA, CMCSA Peacock) facing greater content and licensing pressure and advertisers facing higher CPMs for premium inventory. Competitive dynamics favor bundling and cross‑window leverage, increasing Netflix’s pricing power modestly but raising churn risk if hikes exceed 5–15% in 6–12 months.

Risk assessment: The trade is binary and regulatory: expect a 6–12 month review cycle with a 20–40% chance of heavy remedies or a block; financing risk (large equity raise or >$15–30B debt) could dilute equity and widen Netflix credit spreads by 50–150bps. Hidden dependencies include legacy HBO licensing deals, international carriage rights, and ad‑tier monetization; integration failure or content write‑downs are 10–25% probability tail events. Catalysts to watch: DOJ/FTC filings, EU regulator timelines, Senate hearings, and Netflix quarterly subscriber/ARPU prints over the next 3–9 months.

Trade implications: Tactical approach — size long exposure to NFLX on credible sell‑offs: establish a 2–3% portfolio position on a >10% dip or after a positive regulatory development, target 12–18% upside over 12 months, stop‑loss 15%. Hedge with 3‑month NFLX put spreads (buy 15–25% OTM put, sell 30–40% OTM put) sized to 0.75–1.5% portfolio to cap M&A/regulatory downside. Pair trade: go long NFLX (1.5%) and short DIS (1.0%) or CMCSA (1.0%) to express consolidation benefit while hedging market beta; unwind if relative spread moves >10%.

Contrarian angles: The viral $49.99 price rumor is noise — pricing power is real but limited; a realistic price path is incremental increases (5–25% by segment) not a 2x+ shock. Historical parallels (AOL‑Time Warner, Disney consolidation) show cultural/integration risk and regulatory overreach can destroy expected synergies; options IV spikes around regulatory rulings are often overstated — sell premium tactically post‑announcement. Key documents to act on: DOJ complaint/cure terms, Netflix 8‑K for financing, and quarterly ARPU/subscriber prints within 30–90 days.

Key Decisions for Investors

• Establish a 2–3% long position in NFLX on any >10% post‑rumor sell‑off or on clear positive regulatory wording; target 12–18% upside in 12 months, set a hard stop‑loss at 15%.
• Buy a protective 3‑month NFLX put spread sized to 0.75–1.5% of portfolio (long 15–25% OTM put, short 30–40% OTM put) to cap downside from a regulatory block or financing/dilution event; cost should be <0.5% portfolio.
• Implement a pair trade: long NFLX (1.5% weight) funded by short DIS or CMCSA (1.0% weight) to express Netflix consolidation upside while hedging market beta; rebalance or close if the long/short spread changes >10% or on decisive regulatory outcome within 6–12 months.
• Avoid new meaningful exposure (>1% position) to standalone streaming pure‑plays (e.g., ROKU, PARA) until regulatory clarity (expected 6–12 months) and until Netflix pricing/ARPU actions are disclosed; consider shorting high‑multiple streaming plays on relative weakness.